Guilin Sanjin Pharmaceutical Co., Ltd. (002275.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap8.25B
Enterprise Value7.73B
P/E Ratio16.22
PEG Ratio-1.12
Price/Sales Ratio3.49
Price/Book Ratio2.23
Enterprise/Revenue3.17
Enterprise/EBITDA9.83

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.22
Operating Margin0.28
AD

Management Effectiveness

Return On Assets0.1
Return On Equity0.14

Income Statement

Revenue2.05B
Revenue/Share3.55
Gross Profit1.56B
EBITDA654.91M
Net Income433.13M
Diluted EPS0.74

Balance Sheet

Total Cash1.74B
Total Cash/Share2.94
Total Debt439.78M
Total Debt/Equity0.13
Current Ratio3.97
Book Value Per Share5.61

Price History

52-Week Change-11.9
52-Week High17.38
52-Week Low11.97
Moving Average 50 Days13.69
Moving Average 200 Days14.39

Statistics

Average Volume2.32M
Shares Outstanding587.57M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.5
Trailing Annual Dividend Yield4
Payout Ratio0.75
Last Split Factor13:10
Last Split DateApril 21, 2011
AD